i-SENS Expects Global Export Expansion with Completion of Songdo 2nd Factory
A point to note is that this Songdo Factory features specialized facilities for research & development. The resources used to be dispersed at i-SENS headquarters and at the Wonju Factory so this new facility will allow augmented development for better quality and next-generation advancements. Even more, to allow more active research & development, the Songdo branch features equipment for prototype production which means it will help product testing.
Since 2010, the i-SENS glucometer has grown to become the third most popular product in the industry following Roche and Johnson & Johnson surpassing the sales of not only global companies such as Abbott, Bayer, etc. but also domestic manufacturers in the domestic market. While even global manufacturers are downsizing, i-SENS is gearing up with an astounding growth rate to take over second place in the glucometer industry even though it is known to have fierce competition.
i-SENS CEO Geun Sig Cha said that “The Songdo factory will be a base for an even greater sales growth and position i-SENS in a favorable position to experience a 2nd growth phase based on cutting-edge biosensor technology” and that “moreover, as the Wonju factory has in the Gangwondo region, the 2nd facility is expected to play a similar part in creating stable jobs in the Gyeonggido region.” (Inquiries: +82-2-910-0687, jlee@i-sens.com)
Website: http://i-sens.com
Contact
i-Sens
+82-2-910-0687
Send Email
This news is a press release provided by i-SENS, Inc..